FindMyKOL
Clinical trialNCT02913664CompletedPhase 2/PHASE3Interventional

Risk Reduction for Alzheimer's Disease

SponsorUniversity of Texas Southwestern Medical CenterEnrollment513Cognitively Normal Older AdultsFamily History of Alzheimer's DiseaseHypertensionSubjective Cognitive Decline
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

Physical inactivity, high blood pressure and dyslipidemia are risk factors for Alzheimer's disease (AD) and vascular dementia. Importantly, these risk factors are modifiable with lifestyle changes, pharmacological treatment, or both. The rrAD study will determine effects of aerobic exercise training and intensive vascular risk reduction on cognitive performance in older adults who have high risk for AD.
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

4 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • University of Kansas Medical Center Research Institute

    Kansas City, Kansas, United States

  • Pennington Biomedical Research Center

    Baton Rouge, Louisiana, United States

  • Washington University in St. Louis

    St Louis, Missouri, United States

  • Ut Southwestern Medical Center

    Dallas, Texas, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Angiotensin II receptor blocker and calcium channel blocker
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
2 Feb 2017
Primary completion
30 Nov 2021
Completion
31 Jan 2022
Last update posted
15 Feb 2022
Registered enrollment
513
Registry id
NCT02913664
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 4 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.